1 The GIPR association was specific to tirzepatide, Eli Lilly's dual GLP-1 and GIP receptor agonist sold as Mounjaro and Zepbound, with carriers of that variant found to be 83% more likely to experience vomiting than non-carriers
The content is not intended to encourage application, diagnosis, or self-treatment of unlicensed individuals, and should not be used as a substitute for the clinical judgment of a qualified healthcare provider
What are the treatment options for metastatic MMNST
Before becoming a nutritionist, Alex was a journalist and copywriter
Paired with clinically appropriate add-ons, it's designed to support a different wellness approach than traditional GLP-1 Weight Loss programs
The role of laccase in prostaglandin production by Cryptococcus neoformans